Inhaled iloprost to treat neonatal pulmonary hypertension;Neonatal pulmoner hipertansiyon tedavisinde inhale iloprost kullanimi

Cocuk Sagligi ve Hastaliklari Dergisi

Volumn 48, Issue 2, 2005, Pages 142-146

  Sivasli, Ercan ^a   Yurdakök, Murat ^a   Karagöz, Tevfik ^a   Korkmaz, Ayşe ^a   Yiǧit, Şule ^a   Tekinalp, Gülsevin ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Inhaled iloprost; Newborn; Pulmonary hypertension

Indexed keywords

ILOPROST;

AEROSOL; ARTICLE; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; LUNG ARTERY; MORBIDITY; MORTALITY; NEWBORN; NEWBORN DISEASE; OXYGEN SATURATION; PATHOGENESIS; PULMONARY HYPERTENSION; RESPIRATORY DISTRESS; SIDE EFFECT; TREATMENT OUTCOME; VASOCONSTRICTION; VASODILATATION;

EID: 20044388194     PISSN: 00100161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Yiǧit Ş. Persistan pulmoner hipertansiyon. Yurdakök M, Erdem G. Neonatoloji. Ankara: Nestle Türkiye Gida San. A.Ş., 2004: 447-451.
2. Yurdakök M. Yenidoḡanin persistan pulmoner hipertansiyonu. Özalp İ, Yudakok M, Coşkun T. Pediatride Gelişmeler. Ankara: Güneş Yayinevi, 1999: 200-232.
3. Nair PM, Bataclan MF. Persistent pulmonary hypertension of the newborn. Saudi Med J 2004; 25: 693-699.
4. Aschner JL. New therapies for pulmonary hypertension in neonates and children Pediatr Pulmonol Suppl 2004; 26: 132-135.
5. Olschewski H, Simonneau G, Galie N, et al. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med 2002; 347: 322-329.
6. Kelly LK, Porta NF, Goodman DM, Carroll CL, Steinborn RH. Inhaled prostacyclin for term infants with persisent pulmonary hypertension refractory to inhaled nitric oxide. J Pediatr 2002; 141: 830-832.
7. Oran O, Erdem G, Tekinalp G, Yurdakok M, Yiǧit S. Yenidoǧan Bakimmda Hacettepe Uygulamalari. Ankara: Güneş Yayinevi, 2001: 38-45.
8. Krauss AN. New methods advance treatment for respiratory distress syndrome. Pediatr Ann 2003; 32: 585-591.
9. Aikio O, Saarela T, Pokela ML, Hallman M. Nitric oxide treatment and acute pulmonary inflammatory response in very premature infants with intractable respiratory failure shortly after birth. Acta Paediatr 2003; 92: 65-69.
10. Macrae DJ, Mercier JC, Moller J, et al. Inhaled nitric oxide therapy in neonates and children: reaching a European consensus. Intensive Care Med 2004; 30: 372-380.
11. Yurdakök M, Erdem G, Tekinalp G, Özkutlu S. Neonatal persistan pulmoner hipertansiyonun tedavisi: 32 vakanin deḡerlendirilmesi. Çocuk Saǧliḡi ve Hastaliklari Dergisi 1994; 37: 385-399.
12. Goldsmith DR, Wagstaff A. Inhaled iloprost in primary pulmonary hypertension. Drugs 2004; 64: 763-773.
13. Rimensberger PC, Spahr-Schopfer I, Berner M, et al. Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: vasodilator capacity and cellular mechanism. Circulation 2001; 103: 544-548.
14. Travadi JN, Patole SK. Phosphodiesterase inhibitors for persistent pulmonary hypertension of the newborn. Pediatr Pulmonol 2003; 36: 529-535.
15. Schulze-Neick I, Penny DJ, Rigby ML, et al. L-arginine and substance P reverse the pulmonary endothelial dysfunction caused by congenital heart surgery. Circulation 1999; 100: 749-755.
16. Fargell B. İloprost-stabil bir prostasiklin analoǧu iloprost ile trapötik uygulamalar sempozyumu. 18-19 Şubat 2000, Berlin. Lancaster: Parthenon Medical Communications, 2000.
17. Begetti M, Berner M, Rimensberger PC. Long term inhalation of iloprost in a child with primary pulmonary hypertension: an alternative to continuous infusion. Heart 2001; 86: e10.
18. Hallioglu O, Dilber E, Celiker A. Comparison of acute hemodynamic effects of aerosolized and intravenous iloprost in secondary pulmonary hypertension in children with congenital heart disease. Am J Cardiol 2003; 92: 1007-1009.